Mangalam Drugs (India) Top Management

MANGALAM   79.70  1.53  1.88%   
Mangalam Drugs employs about 432 people. The company is managed by 11 executives with a total tenure of roughly 1008 years, averaging almost 91.0 years of service per executive, having 39.27 employees per reported executive. Analysis of Mangalam Drugs' management performance can provide insight into the company performance.
Govardhan Dhoot  Chairman
Chairman MD
Kamal Vashi  President
President
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mangalam Drugs And. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Mangalam Drugs Management Team Effectiveness

Mangalam Drugs' management efficiency ratios could be used to measure how well Mangalam Drugs manages its routine affairs as well as how well it operates its assets and liabilities.

Mangalam Drugs Workforce Comparison

Mangalam Drugs And is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 89,018. Mangalam Drugs adds roughly 432 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.06 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.06.

Mangalam Drugs And Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Mangalam Drugs And Price Series Summation is a cross summation of Mangalam Drugs price series and its benchmark/peer.

Mangalam Drugs Notable Stakeholders

A Mangalam Drugs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Mangalam Drugs often face trade-offs trying to please all of them. Mangalam Drugs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Mangalam Drugs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Mangalam Drugs Management Performance

The success or failure of an entity such as Mangalam Drugs And often depends on how effective the management is. Mangalam Drugs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Mangalam management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Mangalam management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of Mangalam Drugs' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mangalam Drugs' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mangalam Drugs' management manipulating its earnings.

Mangalam Drugs Workforce Analysis

Traditionally, organizations such as Mangalam Drugs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Mangalam Drugs within its industry.

Mangalam Drugs Manpower Efficiency

Return on Mangalam Drugs Manpower

Revenue Per Employee8.5M
Revenue Per Executive334M
Net Loss Per Employee210K
Net Loss Per Executive8.2M
Working Capital Per Employee276.4K
Working Capital Per Executive10.9M

Complementary Tools for Mangalam Stock analysis

When running Mangalam Drugs' price analysis, check to measure Mangalam Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangalam Drugs is operating at the current time. Most of Mangalam Drugs' value examination focuses on studying past and present price action to predict the probability of Mangalam Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangalam Drugs' price. Additionally, you may evaluate how the addition of Mangalam Drugs to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios